|
|||||
|
|
The backlash against bioequivalence and the interchangeability of brand-name and generic drugs |
|
| Authors: | Aaron S. Kesselheim |
| Affiliation: | Aaron Kesselheim is with the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass. |
| Abstract: | |
| Keywords: | |